SINGH, S. K. . ASSESSING THE LEADER TRIAL: UNDERSTANDING MYOCARDIAL INFARCTION SUBTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS AND THE BENEFICIAL IMPACT OF LIRAGLUTIDE THERAPY. Student’s Journal of Health Research Africa, Africa, v. 4, n. 12, p. 5, 2023. DOI: 10.51168/sjhrafrica.v4i12.865. Disponível em: https://sjhresearchafrica.org/index.php/public-html/article/view/865. Acesso em: 21 nov. 2024.